PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPneumonia
MeSH D011014 - pneumonia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008171:Lung diseases
$
Success rate
D012141:Respiratory tract infections
D011014: 
Pneumonia
D000071067:Necrotizing pneumonia
0 Companies
0 Drugs
Success rate
D000077299:Healthcare-associated pneumonia
0 Companies
0 Drugs
Success rate
D001996:Bronchopneumonia
0 Companies
0 Drugs
Success rate
D011001:Pleuropneumonia
0 Companies
0 Drugs
Success rate
D011015:Aspiration pneumonia
0 Companies
0 Drugs
Success rate
D011020:Pneumocystis pneumonia
D011024:Viral pneumonia
0 Companies
0 Drugs
Success rate
D018410:Bacterial pneumonia
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaFluconazole Fluconazole  2004-07-29   
Sucralfate Sucralfate  1996-03-29   
PadagisBacitracin, Polymyxin b Bacitracin Polymyxin B  2002-02-27   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Bacitracin  1982-01-01   
Taro PharmaceuticalFluconazole Fluconazole  2004-07-29   
Glenmark PharmaceuticalsFluconazole Fluconazole  2006-01-25   
Acetylcysteine Acetylcysteine  2022-02-03   
MylanFluconazole Fluconazole  2004-07-29   
Sucralfate Sucralfate  2022-09-12   
GSKBacitracin, Polymyxin b Polysporin  1985-03-01   
SandozTazobactam, Piperacillin Piperacillin Tazobactam  2010-10-21   
SanofiTelithromycin Levviax  2001-07-09   
WyethPiperacillin Pipracil  1987-10-13   
Tazobactam, Piperacillin Zosyn 2023-04-14 1993-10-22   
Bausch Health CompaniesBacitracin, Polymyxin b Bacitracin Polymyxin B  1995-01-26   
Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Bacitracin  1995-10-30   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone  1995-10-30   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
80%
40/50
Phase 2
63%
65/104
Phase 3
44%
61/138
Approved: 14Overall Success rate: 22%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
GSK
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use